Pyogenic streptococci - danger of re-emerging pathogens

• Autorzy: Sitkiewicz I. , Hryniewicz W.
• Języki publikacji: EN

Abstrakty

EN

ß-hemolytic, pyogenic Streptococci are classified according to type of major surface antigen into A (Streptococcus pyogenes), B (Streptococcus agalactiae), C (multiple species including Streptococcus dysgalactiae) and G (multiple species including Streptococcus canis) Lancefield groups. Group A Streptococcus causes each year hundreds of thousands deaths globally as a result of infections and post-infectional sequelae. An increasing number of severe, invasive infections is caused by selected, specialized pathogenic clones. Within the last 50 years, an increasing number of human infections caused by groups B, C and G Streptococcus (GBS, GCS, GGS) has been observed worldwide. GBS was first identified as animal pathogen but the spectrum of diseases caused by GBS quickly shifted to human infections. Groups C and G Streptococcus are still regarded mostly as animal pathogens, however, an increased number of severe infections caused by these groups is observed. The increasing number of human infections caused worldwide by GCS/GGS can be a sign of similar development from animal to human pathogen as observed in case of GBS and this group will gain much more clinical interest in the future.The situation in Poland regarding invasive infections caused by pyogenic streptococci is underestimated.

Słowa kluczowe

EN

human pathology; animal pathology; Streptococcus; pathogen; Streptococcus pyogenes; Streptococcus agalactiae; Streptococcus dysgalactiae; Streptococcus canis

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2010
• Tom: 59
• Numer: 4
• Opis fizyczny: p.219-226,ref.

Twórcy

autor

Sitkiewicz I.

• Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland

autor

Hryniewicz W.

• Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland

Bibliografia

• Akesson P., A.G. Sjoholm and L. Bjorek. 1996. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J. Biol. Chem. 271: 1081-1088.
• Aziz R.K., R.A. Edwards, W.W. Taylor, D.E. Low, A. McGeer and M. Kotb. 2005. Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J. Bacterial 187: 3311-3318.
• Aziz R.K. and M. Kotb. 2008. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg. Infect. Dis. 14: 1511-1517.
• Badri M.S., S. Zawaneh, A.C. Cruz, G. Mantilla, H. Baer, W.N. Spellacy and E.M. Ayoub. 1977. Rectal colonization with group B Streptococcus: relation to vaginal colonization of pregnant women. J. Infect. Dis. 135: 308-312.
• Baron M.J., G.R. Bolduc, M.B. Goldberg, T.C. Auperin and L.C. Madoff. 2004. Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J. Biol. Chem. 279: 24714-24723.
• Beall B., R. Facklam and T. Thompson. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34: 953-958.
• Beres S.B., G.L. Sylva, K.D. Barbian, B. Lei, J.S. Hoff, N.D. Mammarella, M.Y. Liu, J.C. Smoot, S.F. Porcella, L.D. Parkins, D.S. Campbell, T.M. Smith, J.K. McCormick, D.Y. Leung, P.M. Schlievert and J.M. Musser. 2002. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Nat. Acad. Sci. USA 99: 10078-10083.
• Beres S.B., G.L. Sylva, D.E. Sturdevant, C.N. Granville, M. Liu, S.M. Ricklefs, A.R. Whitney, L.D. Parkins, N.P. Hoe, G.J. Adams, D.E. Low, F.R. DeLeo, A. McGeer and J.M. Musser. 2004. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc. Natl. Acad. Sci. USA 101: 11833-11838.
• Bergmann S. and S. Hammerschmidt. 2007. Fibrinolysis and host response in bacterial infections. Thromb. Haemost. 98: 512-520.
• Bisno A.L., M.O. Brito and CM. Collins. 2003. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3: 191-200.
• Bohach G.A., A.R. Hauscr and P.M. Schlievert. 1988. Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli. Infect. Immun. 56: 1665-7.
• Bohnsack J.F., A. Whiting, M. Gottschalk, D.M. Dunn, R. Weiss, P.H. Azimi, J.B. Philips, 3rd, L.E. Weisman, G.G. Rhoads and F.Y. Lin. 2008. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J. Clin. Microbiol. 46: 1285-1291.
• Bohnsack J.F., K. Widjaja, S. Ghazizadeh, C.E. Rubens, D.R. Hillyard, C.J. Parker, K.H. Albcrtinc and H.R. Hill. 1997. A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections. J. Infect. Dis. 175: 847-855.
• Bolduc G.R., M.J. Baron, C. Gravekamp, CS. Lachenauer and L.C. Madoff. 2002. The alpha C protein mediates internalization of group B Streptococcus within human cervical epithelial cells. Cell. Microbiol. 4: 751-758.
• Bordes-Benitez A., M. Sanchez-Onoro, P. Suarez-Bordon, A.J. Garcia-Rojas, J.A. Saez-Nieto, A. Gonzalez-Garcia, I. Alamo-Antunez, A. Sanchez-Maroto and M. Bolanos-Rivero. 2006. Outbreak of Streptococcus ecjui subsp. tooepidemlcus infections on the island of Gran Canaria associated with the consumption of inadequately pasteurized cheese. Eur. J. Clin. Microbiol. Infect. Dis. 25: 242-246.
• Bradley S.F., J.J. Gordon, D.D. Baumgartner, W.A. Marasco and C.A. Kauffman. 1991. Group C streptococcal bacteremia: analysis of 88 cases. Rev. Infect. Dis. 13: 270-280.
• Brandt C.M. and B. Spellerberg. 2009. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin. Infect. Dis. 49: 766-772.
• Bryan J.D. and D.W. Shelver. 2009. Streptococcus agalactiae CspA is a serine protease that inactivates chemokines. J. Bacteriol. 191: 1847-1854.
• Brzychczy-Wloch M., T. Gosiewski, M. Bodaszewska, W. Pabian, M. Bulanda, P. Kochan, M. Strus and P.B. Heczko. 2010. Genetic characterization and diversity of Streptococcus agalactiae isolates with macrolide resistance. J. Med. Microbiol. 59: 780-786.
• Brzychczy-Wloch M., M. Strus, D. Pawlik, H. Machlarz, T. Gosiewski, A. Drzewiecki, K. Rytlewski, R. Lauterbach and P.B. Heczko. 2008. Increasing Streptococcus agalactiae colonization of pregnant women and newborns in south-eastern region of Poland (in Polish). Med. Dośw. Mikrobiol. 60: 5-12.
• Buchanan J.T., A.J. Simpson, R.K. Aziz, G.Y. Liu, S.A. Kristian, M. Kotb, J. Feramisco and V. Nizet. 2006. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr. Biol. 16: 396-400.
• Carapetis J.R., A.C. Steer, E.K. Mulholland and M. Weber. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5: 685-694.
• Carlsson F., C. Sandin and G. Lindahl. 2005. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol. Microbiol. 56: 28-39.
• CDC. 2007. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Morb. Mortal. Wkly. Rep. 59: RRIO
• Cheng Q., D. Stafslien, S.S. Purushothaman and P. Cleary. 2002. The group B streptococcal C5a peptidase is both a specific protease and an invasin. Infect. Immun. 70: 2408-2413.
• Chiang-Ni C. and J.J. Wu. 2008. Effects of streptococcal pyrogenic exotoxin B on pathogenesis of Streptococcus pyogenes. J. Formos. Med. Assoc. 107: 677-685.
• Cleary P.P., E.L. Kaplan, J.P. Handley, A. Wlazlo, M.H. Kim, A. R. Hauser and P.M. Schlievert. 1992. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 339: 518-521.
• Collin M. and A. Olsen. 2003. Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect. Immun. 71: 2983-2992.
• Creti R., F. Fabretti, G. Orefici and C. von Hunolstein. 2004. Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes. J. Clin. Microbiol. 42: 1326-1329.
• Cunningham M.W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13: 470-511.
• Daneman N., K.A. Green, D.E. Low, A.E. Simor, B. Willey, B. Schwartz, B. Toye, P. Jessamine, G.J. Tyrrell, S. Krajden, L. Ramage, D. Rose, R. Schertzberg, D. Bragg and A. McGeer. 2007. Surveillance for hospital outbreaks of invasive group A streptococcal infections in Ontario, Canada, 1992 to 2000. Ann. Intern. Med. 147: 234-241.
• Daugaard H.O., A.C. Thomsen, U. Henriques and A. Ostergaard. 1988. Group B streptococci in the lower urogenital tract and late abortions. Am. J. Obstet. Gynecol. 158: 28-31.
• Davies H.D., A. McGeer, B. Schwartz, K. Green, D. Cann, A.E. Simor and D.E. Low and Ontario Group A Streptococcal Study Group. 1996. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 335: 547-554.
• Edwards R.J., G.W. Taylor, M. Ferguson, S. Murray, N. Rendell, A. Wrigley, Z. Bai, J. Boyle, S.J. Finney, A. Jones, H.H. Russell, C. Turner, J. Cohen, L. Faulkner and S. Sriskandan. 2005. Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J. Infect. Dis. 192: 783-790.
• Efstratiou A. 1989. Outbreaks of human infection caused by pyogenic streptococci of Lancefield groups C and G.J. Med, Microbiol. 29: 207-219.
• Efstratiou A. 1997. Pyogenic streptococci of Lancefield groups C and G as pathogens in man. Soc. Appl. Bacteriol. Symp. Ser. 26: 72S-79S.
• Facklam R. 2002. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin. Microbiol. Rev 15: 613-630.
• Foxman B., B. Gillespie, S.D. Manning, L.J. Howard, P. Tallman, L. Zhang and C.F. Marrs. 2006. Incidence and duration of group B Streptococcus by serotype among male and female college students living in a single dormitory. Am. J. Epidemiol. 163: 544-551.
• Fraser J., V. Arcus, P. Kong, E. Baker and T. Proft. 2000. Super-antigens - powerful modifiers of the immune system. Mol. Med. Today 6: 125-132.
• Green N.M., S.B. Beres, E.A. Graviss, J.E. Allison, A.J. McGeer, J. Vuopio-Varkila, R.B. LeFebvre and J.M. Musser. 2005a. Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J. Clin. Microbiol. 43: 4083-4091.
• Green N.M., S. Zhang, S.F. Porcella, M.J. Nagiec, K.D. Barbian, S.B. Beres, R.B. LeFebvre and J.M. Musser. 2005b. Genome sequence of a serotype M28 strain of group A Streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J. Infect. Dis. 192: 760-770.
• Hardie J.M. and R.A. Whiley. 1997. Classification and overview of the genera Streptococcus and Enterococcus. Soc. Appl. Bacteriol. Symp. Ser. 26: 1S-11S.
• Harris T.O., D.W. Shelver, J.F. Bohnsack and C.E. Rubens. 2003. A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J. Clin. Invest. 111: 61-70.
• Hensler M.E., D. Quach, C.J. Hsieh, K.S. Doran and V. Nizet. 2008. CAMP factor is not essential for systemic virulence of Group B Streptococcus. Microb. Pathog. 44: 84-88.
• Hynes W.L., A.R. Dixon, S.L. Walton and L.J. Aridgides. 2000. The extracellular hyaluronidase gene (hylA) of Streptococcus pyogenes. FEMS Microbiol. Lett. 184: 109-112.
• Ikebe T., Y. Oguro, K. Ogata, C. Katsukawa, J. Isobc, T. Shima, R. Suzuki, H. Ohya, K. Tominaga, R. Okuno, Y. Uchitani, Y. Tada, N. Okabe and H. Watanabe. 2010. Surveillance of severe invasive group G streptococcal infections in Japan during 2002-2008. Jpn. J. Infect. Dis. 63: 372-375.
• Isaacman D.J., E.D. McIntosh and R.R. Reinert. 2010. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children In Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int. J. Infect. Dis. 14: 197-209.
• Ji Y., L. McLandsborough, A. Kondagunta and P.P. Cleary. 1996. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64: 503-510.
• Johnson D.R., E.L. Kaplan, A. VanGheem, R.R. Facklam and B. Beall. 2006. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J. Med. Microbiol. 55: 157-164.
• Jones N., K.A. Oliver, J. Barry, R.M. Harding, N. Bisharat, B.G. Spratt, T. Peto and D.W. Crook. 2006. Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B Streptococcus is independent of capsular serotype. Clin. Infect. Dis. 42: 915-924.
• Keefe G.P., I.R. Dohoo and E. Spangler. 1997. Herd prevalence and incidence of Streptococcus agalactiae in the dairy industry of Prince Edward Island. J. Dairy. Sci. 80: 464-470.
• Kohler W. 2007. The present state of species within the genera Streptococcus and Enterococcus. Int. J. Med. Microbiol. 297: 133-150.
• Kotarski J., P.B. Heczko, R. Lauterbach, T. Niemiec, B. Leszczynska-Gorzelak and Polish Gynecological Society. 2008. Polish Gynecological Society's recommendations regarding diagnosis and prevention of Streptococcus agalactiae infection in pregnant women and newborns. Ginekol. Pol. 79: 221-223.
• Kurupati P., C.E. Turner, I. Tziona, R.A. Lawrenson, F.M. Alam, M. Nohadani, G.W. Stamp, A.S. Zinkernagel, V. Nizet, R.J. Edwards and S. Sriskandan. 2010. Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract. Mol. Microbiol, 76: 1387-1397.
• Lamagni, T. L., J. Darenberg, B. Luca-Harari, T. Siljander, A. Efstratiou, B. Henriques-Normark, J. Vuopio-Varkila, A. Bouvet, R. Creti, K. Ekelund, M. Koliou, R. R. Reinert, A. Stathi, L. Strakova, V. Ungureanu, C. Schalen and A. Jasir. 2008. Epidemiology of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 46: 2359-2367.
• Lancefield R.C. 1933. A serological differentiation of human and other groups of hemolytic streptococci. J. Exp. Med. 57: 571-595.
• Lancefield R.C. and R. Hare. 1935. The serological differentiation of pathogenic and non-pathogenic strains of hemolytic streptococci from parturient women. J. Exp. Med. 61: 335-349.
• Lancefield, R. C. and E.W. Todd. 1928. Antigenic differences between matt hemolytic streptococci and their glossy variants. J. Exp. Med. 48: 769-790.
• Lang S. and M. Palmer. 2003. Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. J. Biol. Chem. 278: 38167-38173.
• Lauer P., C.D. Rinaudo, M. Soriani, I. Margarit, D. Maione, R. Rosini, A.R. Taddei, M. Mora, R. Rappuoli, G. Grandi and J.L. Telford. 2005. Genome analysis reveals pili in Group B Streptococcus. Science 309: 105.
• Lei B., F.R. DeLeo, N.P. Hoe, M.R. Graham, S.M. Mackie, R.L. Cole, M. Liu, H.R. Hill, D.E. Low, M.J. Federle, J.R. Scott and J.M. Musser. 2001. Evasion of human innate and acquired immunity by a bacterial homolog of CD1 lb that inhibits opsonophagocytosis. Nat. Med. 1: 1298-1305.
• Luan S.L., M. Granlund, M. Sellin, T. Lagergard, B.G. Spratt and M. Norgren. 2005. Multilocus sequence typing of Swedish invasive group B Streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J. Clin. Microbiol. 43: 3727-3733.
• Luca-Harari B., J. Darenberg, S. Neal, T. Siljander, L. Strakova, A. Tanna, R. Creti, K. Ekelund, M. Koliou, P.T. Tassios, M. van der Linden, M. Straut, J. Vuopio-Varkila, A. Bouvet, A. Efstratiou, C. Schalen, B. Henriques-Normark and A. Jasir. 2009. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 41: 1155-1165.
• Maisey H.C., K.S. Doran and V. Nizet. 2008. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert. Rev. Mol Med. 10: e27.
• Marchandin H., E. Jumas-Bilak, A. Boumzebra, D. Vidal, O. Jonquet and P. Corne. 2007. Fatal Streptococcus equi subsp. ruminatorum infection in a man. Emerg. Infect. Dis. 13: 1964-1966.
• McDonald H.M. and H.M. Chambers. 2000. Intrauterine infection and spontaneous midgestation abortion: is the spectrum of microorganisms similar to that in preterm labor? Infect. Dis. Obstet. Gynecol. 8: 220-227.
• McNeil S.A., S.A. Halperin, J.M. Langley, B. Smith, A. Warren, G.P. Sharratt, D.M. Baxendale, M.A. Reddish, M.C. Hu, S.D. Stroop, J. Linden, L.F. Fries, P.E. Vink and J.B. Dale. 2005. Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41: 1114-1122.
• Mohr D.N., D.J. Feist J.A. Washington, 2nd and P.E. Hermans. 1979. Infections due to group C streptococci in man. Am. J. Med. 66: 450-456.
• Nizet V. 2002. Streptococcal beta-hemolysins: genetics and role in disease pathogenesis. Trends. Microbiol. 10: 575-580.
• Nobbs A.H., R.J. Lamont and H.F. Jenkinson. 2009. Streptococcus adherence and colonization. Microbiol. Mol. Biol. Rev. 73: 407-450.
• Pahlman L.I., M. Morgelin, J. Eckert, L. Johansson, W. Russell, K. Riesbeck, O. Soehnlein, L. Lindbom, A. Norrby-Teglund, R.R. Schumann, L. Bjorek and H. Herwald. 2006. Streptococcal M protein: a multipotent and powerful inducer of inflammation. J. Immunol. 177: 1221-1228.
• Perez-Caballero D., I. Garcia-Laorden, G. Cortes, M.R. Wessels, S.R. de Cordoba and S. Alberti. 2004. Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involves two different cell surface molecules. J. Immunol. 173: 6899-6904.
• Phares C.R., R. Lynfield, M.M. Farley, J. Mohle-Boetani, L.H. Harrison, S. Petit, A.S. Craig, W. Schaffner, S.M. Zansky, K. Gershman, K.R. Stefonek, B.A. Albanese, E.R. Zell, A. Schuchat and S.J. Schrag. 2008. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. Jama 299: 2056-2065.
• Pletz M.W., U. Maus, N. Krug, T. Welte and H. Lode. 2008. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int. J. Antimicrob. Agents. 32: 199-206.
• Quevedo S.F., D.J. Mikolich, D.E. Humbyrd and A.E. Fisher. 1987. Pyogenic sacroiliitis caused by group G Streptococcus. Arthritis Rheum 30: 115.
• Sadowy E., B. Matynia and W. Hryniewicz. 2010. Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland. J. Antimicrob. Chemother. 65: 1907-1914.
• Salata R.A., P.I. Lerner, D.M. Shlaes, K.V. Gopalakrishna and E. Wolinsky. 1989. Infections due to Lancefield group C streptococci. Medicine (Baltimore) 68: 225-239.
• Samen U., B.J. Eikmanns, D.J. Reinscheid and F. Borges. 2007. The surface protein Srr-1 of Streptococcus agalactiae binds human keratin 4 and promotes adherence to epithelial HEp-2 cells. Infect. Immun. 75: 5405-5414.
• Shet A. and P. Ferrieri. 2004. Neonatal & maternal group B streptococcal infections: a comprehensive review. Indian. J. Med. Res. 120: 141-150.
• Sitkiewicz L, M.J. Nagiec, P. Sumby, S.D. Butler, C. Cywes-Bentley and J.M. Musser. 2006. Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. Proc. Natl. Acad. Sci. USA 103: 16009-16014.
• Skoczynska A., M. Kadlubowski, I. Wasko, J. Fiett and W. Hryniewicz. 2007. Resistance patterns of selected respiratory tract pathogens in Poland. Clin. Microbiol. Infect. 13: 377-383.
• Smoot J.C., K.D. Barbian, J.J. Van Gompel, L.M. Smoot, M.S. Chaussee, G.L. Sylva, D.E. Sturdevant, S.M. Ricklefs, S.F. Porcella, L.D. Parkins, S.B. Beres, D.S. Campbell, T.M. Smith, Q. Zhang, V. Kapur, J.A. Daly, L.G. Veasy and J.M. Musser. 2002a. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. USA 99: 4668-4673.
• Smoot J.C., E.K. Korgenski, J.A. Daly, L.G. Veasy and J.M. Musser. 2002b. Molecular analysis of group A Streptococcus type emmlS isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J. Clin. Microbiol. 40: 1805-1810.
• Sorensen U.B., K. Poulsen, C. Ghezzo, I. Margarit and M. Kilian. 2010. Emergence and Global Dissemination of Host-Specific Streptococcus agalactiae Clones. MBio 1.
• Springman A.C, D.W. Lacher, G. Wu, N. Milton, T.S. Whittam, H.D. Davies and S.D. Manning. 2009. Selection, recombination, and virulence gene diversity among group B streptococcal genotypes. J. Bacteriol. 191: 5419-5427.
• Steer A.C, I. Law, L. Matatolu, B.W. Beall and J.R. Carapetis. 2009. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9: 611-616.
• Strus M., A. Drzewieeki, A. Chmielarczyk, A. Tomusiak, P. Romanek, K. Kosowski, P. Kochan, M. van der Linden, R. Lutticken and P.B. Heczko. 2009a. Microbiological investigation of a hospital outbreak of invasive group A streptococcal disease in Krakow, Poland. Clin. Microbiol. Infect.
• Strus M., D. Pawlik, M. Brzychczy-Wloch, T. Gosiewski, K. Rytlewski, R. Lauterbach and P.B. Heczko. 2009b. Group B Streptococcus colonization of pregnant women and their children observed on obstetric and neonatal wards of the University Hospital in Krakow, Poland. J. Med. Microbiol. 58: 228-233.
• Sumby P., K.D. Barbian, D.J. Gardner, A.R. Whitney, D.M. Welty, R.D. Long, J.R. Bailey, M.J. Parnell, N.P. Hoe, G.G. Adams, F.R. Deleo and J.M. Musser. 2005a. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc. Natl. Acad. Sci. USA 102: 1679-1684.
• Sumby P., S.F. Porcella, A.G. Madrigal, K.D. Barbian, K. Virtaneva, S.M. Ricklefs, D.E. Sturdevant, M.R. Graham, J. Vuopio-Varkila, N.P. Hoe and J.M. Musser. 2005b. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J. Infect. Dis. 192: 771-782.
• Sumby, P., S. Zhang, A.R. Whitney, F. Falugi, G. Grandi, E.A. Graviss, F.R. Deleo and J.M. Musser. 2008. A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect. Immun. 76: 978-985.
• Szczypa K., E. Sadowy, R. Izdebski and W. Hryniewicz. 2004. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J. Antimicrob. Chemother. 54: 828-831. Szczypa K., E. Sadowy, R. Izdebski, L. Strakova and W. Hryniewicz. 2006. Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. J. Clin. Microbiol. 44: 3975-3979.
• Takahashi S., Y. Nagano, N. Nagano, O. Hayashi, F. Taguchi and Y. Okuwaki. 1995. Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing. Infect. Immun. 63: 4764-4769.
• van der Mee-Marquet N., L. Fourny, L. Arnault, A.S. Domelier, M. Salloum, M.F. Lartigue and R. Quentin. 2008. Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites. J. Clin. Microbiol. 46: 2906-2911.
• Vandamme P., B. Pot, E. Falsen, K. Kersters and L.A. Devriese. 1996. Taxonomic study of Lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov. Int. J. Syst. Bacteriol. 46: 774-781.
• von Pawel-Rammingen U., B.P. Johansson and L. Bjorek. 2002. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. Embo. J. 21: 1607-1615.
• Walker M.J., A. Hollands, M.L. Sanderson-Smith, J.N. Cole, J.K. Kirk, A. Henningham, J.D. McArthur, K. Dinkla, R.K. Aziz, R.G. Kansal, A.J. Simpson, J.T. Buchanan, G.S. Chhatwal, M. Kotb and V. Nizet. 2007. DNase Sda1 provides selection pressure for a switch to invasive group A Streptococcal infection. Nat. Med. 13: 981-985.
• Whitney C.G., M.M. Farley, J. Hadler, L.H. Harrison, N.M. Bennett, R. Lynfield, A. Reingold, P.R. Cieslak, T. Pilishvili, D. Jackson, R.R. Facklam, J.H. Jorgensen and A. Schuchat. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348: 1737-46.